These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
178 related articles for article (PubMed ID: 25756697)
21. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group. Archer DF; Pickar JH; Bottiglioni F Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926 [TBL] [Abstract][Full Text] [Related]
22. Disturbances of endometrial bleeding with hormone replacement therapy. Thomas AM; Hickey M; Fraser IS Hum Reprod; 2000 Aug; 15 Suppl 3():7-17. PubMed ID: 11041216 [TBL] [Abstract][Full Text] [Related]
23. Breast cancer risk with postmenopausal hormonal treatment. Collins JA; Blake JM; Crosignani PG Hum Reprod Update; 2005; 11(6):545-60. PubMed ID: 16150813 [TBL] [Abstract][Full Text] [Related]
24. [HRT in post-menopausal women: endometrial histology and bleeding patterns]. Lo Dico G; Alongi G; Spinelli MP; Cannariato P; Lucido AM Minerva Ginecol; 2002 Aug; 54(4):361-6. PubMed ID: 12114870 [TBL] [Abstract][Full Text] [Related]
25. Postmenopausal hormone replacement therapy use and risk of endometrial cancer in Japanese women. Mizunuma H; Honjo H; Aso T; Urabe M; Ohta H; Kobayashi S; Sagara Y; Sanada M; Tanaka K; Dobashi K; Hayashi K; Ohama K Climacteric; 2001 Dec; 4(4):293-8. PubMed ID: 11770185 [TBL] [Abstract][Full Text] [Related]
26. Long-term use of postmenopausal estrogen and progestin hormone therapies and the risk of endometrial cancer. Doherty JA; Cushing-Haugen KL; Saltzman BS; Voigt LF; Hill DA; Beresford SA; Chen C; Weiss NS Am J Obstet Gynecol; 2007 Aug; 197(2):139.e1-7. PubMed ID: 17689625 [TBL] [Abstract][Full Text] [Related]
27. Effects of postmenopausal hormone therapy on incident atrial fibrillation: the Women's Health Initiative randomized controlled trials. Perez MV; Wang PJ; Larson JC; Virnig BA; Cochrane B; Curb JD; Klein L; Manson JE; Martin LW; Robinson J; Wassertheil-Smoller S; Stefanick ML Circ Arrhythm Electrophysiol; 2012 Dec; 5(6):1108-16. PubMed ID: 23169946 [TBL] [Abstract][Full Text] [Related]
28. Postmenopausal vaginal bleeding in women using hormone replacement therapy. Burbos N; Musonda P; Duncan TJ; Crocker SG; Nieto JJ; Morris EP Menopause Int; 2012 Mar; 18(1):5-9. PubMed ID: 22323674 [TBL] [Abstract][Full Text] [Related]
29. Prevention of osteoporosis and uterine effects in postmenopausal women taking raloxifene for 5 years. Jolly EE; Bjarnason NH; Neven P; Plouffe L; Johnston CC; Watts SD; Arnaud CD; Mason TM; Crans G; Akers R; Draper MW Menopause; 2003; 10(4):337-44. PubMed ID: 12851517 [TBL] [Abstract][Full Text] [Related]
30. Endometrial response to raloxifene compared with placebo, cyclical hormone replacement therapy, and unopposed estrogen in postmenopausal women. Davies GC; Huster WJ; Shen W; Mitlak B; Plouffe L; Shah A; Cohen FJ Menopause; 1999; 6(3):188-95. PubMed ID: 10486787 [TBL] [Abstract][Full Text] [Related]
31. Risk of endometrial cancer following estrogen replacement with and without progestins. Weiderpass E; Adami HO; Baron JA; Magnusson C; Bergström R; Lindgren A; Correia N; Persson I J Natl Cancer Inst; 1999 Jul; 91(13):1131-7. PubMed ID: 10393721 [TBL] [Abstract][Full Text] [Related]
32. Endometrial effect of progesterone delivered by vaginal rings in estrogen-treated postmenopausal women. Noé G; Sitruk-Ware R; Zegers-Hochschild F; Variano B; Montero JC; Arriagada P; Li A; Stanczyk FZ; Felix JC; Mishell DR; Croxatto HB Climacteric; 2010 Oct; 13(5):433-41. PubMed ID: 20642326 [TBL] [Abstract][Full Text] [Related]
33. Hormone replacement therapy and breast cancer risk in Kyushu University Hospital: supporting the Women's Health Initiative study. Nozaki M; Koera K; Nagata H; Nakano H J Obstet Gynaecol Res; 2004 Aug; 30(4):297-302. PubMed ID: 15238106 [TBL] [Abstract][Full Text] [Related]
34. Qualitative cross-cultural exploration of vaginal bleeding/spotting symptoms and impacts associated with hormone therapy in post-menopausal women to inform the development of new patient-reported measurement tools. Arbuckle R; Humphrey L; Abraham L; Dennerstein L; Simon JA; Mirkin S; Bonner N; Walmsley S; Tatlock S; Symonds T Maturitas; 2014 Jul; 78(3):219-27. PubMed ID: 24856282 [TBL] [Abstract][Full Text] [Related]
35. Mechanisms of irregular bleeding with hormone therapy: the role of matrix metalloproteinases and their tissue inhibitors. Hickey M; Crewe J; Mahoney LA; Doherty DA; Fraser IS; Salamonsen LA J Clin Endocrinol Metab; 2006 Aug; 91(8):3189-98. PubMed ID: 16684831 [TBL] [Abstract][Full Text] [Related]